Pfizer Cibinqo gets USFDA nod to treat Atopic Dermatitis Ruchika Sharma15 Jan 2022 12:00 PM ISTNew York: Pfizer Inc. has announced that the United States (U.S.) Food and Drug Administration (FDA) has approved CIBINQO (abrocitinib), an oral,...
JnJ COVID booster 85 percent effective against Omicron hospitalisation: SAMRC Ruchika Sharma15 Jan 2022 11:00 AM ISTJohannesburg: A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for...
Covaxin now universal vaccine for adults, children, says Bharat Biotech Ruchika Sharma15 Jan 2022 9:00 AM ISTNew Delhi: Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday announced that its indigenously developed COVID-19 vaccine Covaxin is now a...
Pfizer COVID booster can be given along with pneumonia shot: Study Ruchika Sharma14 Jan 2022 4:39 PM ISTNew Delhi: Pfizer Inc said on Wednesday booster doses of its COVID-19 vaccine can be administered along with its pneumonia vaccine and produced...
Aurobindo Pharma gets USFDA warning letter for Hyderabad facility over poor manufacturing practices Ruchika Sharma14 Jan 2022 4:03 PM ISTNew Delhi: Drugmaker, Aurobindo Pharma has announced that the company has received a warning letter from the US Food and Drug Administration...
Bharat Biotech seeks DCGI full marketing nod for Covaxin Ruchika Sharma14 Jan 2022 1:12 PM ISTNew Delhi: Bharat Biotech has sought from the Drugs Controller General of India regular market approval for its COVID-19 vaccine 'Covaxin', which...
Sanofi India Managing Director Rajaram Narayanan resigns Ruchika Sharma14 Jan 2022 12:11 PM ISTMumbai: Sanofi India Limited has announced that its Board of Directors have accepted the resignation of its Managing Director, Rajaram Narayanan,...
Glenmark Pharma arm secures USFDA nod for Ryaltris nasal spray Ruchika Sharma14 Jan 2022 11:44 AM ISTMumbai: Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark...
Moderna to report COVID vaccine data for children aged 2-5 in March Ruchika Sharma13 Jan 2022 4:35 PM ISTNew Delhi: Moderna Inc said it expects to report data from its Covid-19 vaccine trial in children aged between 2 to 5 years in March."If the data is...
Covishield 3rd dose increases antibody response against Omicron, says Study MD Bureau13 Jan 2022 3:52 PM ISTLondon: A third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron...
HCAH raises Rs 112 crore to build largest out of hospital healthcare delivery platform in India Ruchika Sharma13 Jan 2022 2:07 PM ISTNew Delhi: Health-tech company HCAH (HealthCare atHOME) has raised Rs 112 crore from ABC World Asia ("ABC"), a Singapore based impact-focused...
Covaxin booster dose shows neutralising effect on Omicron, Delta variants, states Study Ruchika Sharma13 Jan 2022 1:08 PM ISTNew Delhi: Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta...
